Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIDDIES: Nasal Dexmedetomidine for Postoperative Delirium Prevention
NCT07538284Phase 3Not yet recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dexmedetomidine in postoperative delirium (POD), sleep disorders, sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Planned start May 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)sleep disorders
Beyond the preview
Go deeper on NCT07538284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07538284.